| |
|
|
INAUGURAL LECTURER
- Trevor M Jones CBE (Allergan Inc, UK)
Meeting the Global Challenge of Better Health for all …Are we winning?
CONFIRMED PLENARY LECTURERS
Kevan Shokat (University of California, San Francisco, USA)
Graeme Milligan (University of Glasgow, UK)
Jan van der Greef (TNO Systems Biology, NL)
CONFIRMED KEY LECTURERS
Alan P. Kozikowski (U of Illinois at Chicago, USA)
Andreas Termin (Vertex Pharma., USA)
Andrew Baxter (AstraZeneca, UK)
Antonello Mai (U of Roma, Italy)
Balazs Sarkadi (National Medical Center, Hungary)
Bernd Clement (U of Kiel, Germany)
Brian Shoichet (UCSF, USA)
Daniel Flynn (Deciphera Pharma., USA)
David Rees (Astex Tech., UK)
Eric De Clercq (Katholieke U Leuven, Belgium)
Garret A. Fitzgerald (U of Pennsylvania, USA)
Han van de Waterbeemd (AstraZeneca, UK)
Harel Weinstein (Cornell U, USA)
Hugo Kubinyi (U of Heidelberg, Germany)
|
|
Jürgen Sandkühler (U of Wien, Austria)
Kazunori Kataoka (U of Tokyo, Japan)
Kevan Shokat (UCSF, USA)
Klaus P. Bøgesø (Lundbeck, Denmark)
Koen Augustyns (U of Antwerp, Belgium)
Mark L. Mayer (NIH, USA)
Michael Eck (Harvard Medical School, USA)
Mike Eaton (UCB Celltech, UK)
Philip Portoghese (U of Minnesota, USA)
Scott Taylor (U of Waterloo, Canada)
Timothy M. Willson (GSK, USA)
Trevor Laird (Scientific Update, UK)
Wayne Childers (Wyeth, USA)
Wilfred van der Donk (U of Illinois, USA)
|
CONFIRMED LECTURERS
A. Bombrun (Serono, Switzerland)
A. Gilbert (Wyeth, USA)
A. Kazantsev (Harvard U, USA)
A. Rostami (U of Sheffield, UK)
C. Charlier (U of Paix, Belgium)
D. Erlanson (Sunesis, USA)
D. J. Payne (GSK, USA)
D. Leysen (Devgen, Belgium)
D. Triggle (U of Bufalo, USA)
E. Jacoby (Novartis, Switzerland)
E. Yeþilada (Yeditepe U, Turkey)
F. E. Koehn (Wyeth, USA)
F. Kratz (U of Freiburg, Germany)
G. Cruciani (U of Perugia, Italy)
G. Gaviraghi (Sienabiotech, Italy)
G. Purstinger (Leopold-Franzens-U, Austria)
G. Ronsisvalle (U of Catania, Italy)
G. Siegal (Leiden U, NL)
H. Irth (Vrije U, NL)
H. Weinmann (Schering AG, Germany)
H.-J. Federsel (AstraZeneca, Sweden)
J. Guillemont (Johnson&Johnson, France)
J. J. Heeres (Johnson&Johnson, Belgium)
J. L. Primeau (AstraZeneca, USA)
J. Medina (Amgen, USA)
J. W. Daly (NIH, USA)
J.-P. Pin (U of Montpellier, France)
K. Van Emelen (Janssen Res. Found., Belgium)
L. F. Hennequin (AstraZeneca, France)
L. Patterson (U of Bradford, UK)
L.F. Rodella (U of Brescia, Italy)
| |
M. Dang (Metabasis Ther, USA)
M. Shultz (Novartis, USA)
M. Van Eis (Novartis, Switzerland)
N. Birdsall (NIMR, UK)
N. Noyanalpan (Gazi U, Turkey)
O. Lomowskaya (Mpex, USA)
P. A. Grimaldi (U of Nice, France)
P. Krogsgaard-Larsen (Danish U, Denmark)
P. M. O' Neill (U of Liverpool, UK)
P. Rybczynski (Johnson&Johnson, USA)
P. Senter (SeattleGenetics, USA)
P. Smith (GSK, UK)
R. Jones (Arena, USA)
R. Leurs (Vrije U, NL)
R. Pellicciari (U of Perugia, Italy)
S. Ekins (GeneGo, USA)
S. Lummis (U of Cambridge, UK)
S. S. Bhagwat (Ambit Bio., USA)
S.-S. Feng (Natl U of Singapore, Singapore)
S. van Boeckel (Organon, USA)
T. Kapoor (Rockefeller U, USA)
T. Owa (Eisai, Japan)
T. Willson (GSK, USA)
V. de Groot (Syntarga, NL)
V. Gillett (U of Sheffield, UK)
W. A. Denny (U of Auckland, New Zealand)
W. J. Greenlee (ScheringPlough, USA)
W. Sippl (Martin-Luther U, Germany)
Y. Marantz (Predix, Israel)
Z. Li-he (Peking U, China)
|
Medical Grade Silver - Ionic & Colloidal
|
|
